CIBC World Markets Inc. purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 34,243 shares of the pharmacy operator’s stock, valued at approximately $2,682,000.

Several other hedge funds also recently modified their holdings of the company. State Street Corp increased its stake in shares of Walgreens Boots Alliance by 1.8% in the first quarter. State Street Corp now owns 37,612,843 shares of the pharmacy operator’s stock valued at $3,123,757,000 after buying an additional 677,743 shares during the period. Wellington Management Group LLP grew its stake in Walgreens Boots Alliance by 5.9% during the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after purchasing an additional 1,824,300 shares during the period. Nordea Investment Management AB grew its stake in Walgreens Boots Alliance by 26.5% during the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock worth $760,267,000 after purchasing an additional 1,917,082 shares during the period. TIAA CREF Investment Management LLC grew its stake in Walgreens Boots Alliance by 22.4% during the first quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock worth $437,632,000 after purchasing an additional 962,959 shares during the period. Finally, Legal & General Group Plc grew its stake in Walgreens Boots Alliance by 5.2% during the second quarter. Legal & General Group Plc now owns 4,550,856 shares of the pharmacy operator’s stock worth $356,368,000 after purchasing an additional 223,186 shares during the period. 60.24% of the stock is owned by institutional investors.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at $66.87 on Friday. The company has a market capitalization of $67,508.55, a price-to-earnings ratio of 13.11, a P/E/G ratio of 1.19 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a fifty-two week low of $63.82 and a fifty-two week high of $88.00. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business’s revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.07 earnings per share. analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.

Walgreens Boots Alliance declared that its board has initiated a share repurchase program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s management believes its shares are undervalued.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be paid a $0.40 dividend. The ex-dividend date is Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.39%. Walgreens Boots Alliance’s payout ratio is presently 42.33%.

Several equities research analysts recently commented on the company. Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Monday, October 30th. Citigroup Inc. decreased their target price on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday. Credit Suisse Group reaffirmed a “buy” rating and set a $97.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, July 13th. Jefferies Group LLC set a $93.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Sunday, October 29th. Finally, Pivotal Research decreased their target price on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a research note on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company’s stock. Walgreens Boots Alliance presently has a consensus rating of “Buy” and an average target price of $87.63.

In other Walgreens Boots Alliance news, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Insiders own 13.50% of the company’s stock.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.watchlistnews.com/cibc-world-markets-inc-takes-position-in-walgreens-boots-alliance-inc-wba/1679675.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.